Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 04 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Contract Research Organization (CRO) and CDMO for Pharmaceutical demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Contract Research Organization (CRO) and CDMO for Pharmaceutical, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Contract Research Organization (CRO) and CDMO for Pharmaceutical that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical total market, 2018-2029, (USD Million)
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical total market, key domestic companies and share, (USD Million)
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical revenue by player and market share 2018-2023, (USD Million)
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical total market by Type, CAGR, 2018-2029, (USD Million)
Global Contract Research Organization (CRO) and CDMO for Pharmaceutical total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IQVIA, ICON (Incl. PRA), Labcorp, Syneos Health, PPD (Thermo Fisher), Medpace, Parexel, Wuxi Apptec and Charles River, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Contract Research Organization (CRO) and CDMO for Pharmaceutical market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, Segmentation by Type
    Preclinical CROs
    Clinical CROs

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market, Segmentation by Application
    Pharmaceutical & Biotechnological Companies
    Medical Device Companies
    Academic & Research Institutes
    Others

Companies Profiled:
    IQVIA
    ICON (Incl. PRA)
    Labcorp
    Syneos Health
    PPD (Thermo Fisher)
    Medpace
    Parexel
    Wuxi Apptec
    Charles River
    Pharmaron
    EPS International
    Worldwide Clinical Trials
    CMIC
    Inotiv
    JOINN Lab
    ChemPartner
    Medicilon
    EVOTEC

Key Questions Answered
1. How big is the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market?
2. What is the demand of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market?
3. What is the year over year growth of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market?
4. What is the total value of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market?
5. Who are the major players in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
    1.2 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Market by Region (by Headquarter Location)
        1.3.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.3 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.5 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.6 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.7 ASEAN Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
        1.3.8 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.2 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region
        2.2.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2018-2023)
        2.2.2 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Forecast by Region (2024-2029)
    2.3 United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.4 China Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.5 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.6 Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.7 South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.8 ASEAN Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)
    2.9 India Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029)

3 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies Competitive Analysis
    3.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Contract Research Organization (CRO) and CDMO for Pharmaceutical in 2022
        3.2.3 Global Concentration Ratios (CR8) for Contract Research Organization (CRO) and CDMO for Pharmaceutical in 2022
    3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Company Evaluation Quadrant
    3.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Overall Company Footprint Analysis
        3.4.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Region Footprint
        3.4.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Type Footprint
        3.4.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Comparison
        4.2.1 United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies and Market Share, 2018-2023
        4.3.1 United States Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023)
    4.4 China Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue and Market Share, 2018-2023
        4.4.1 China Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023)
    4.5 Rest of World Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Preclinical CROs
        5.2.2 Clinical CROs
    5.3 Market Segment by Type
        5.3.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2018-2023)
        5.3.2 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2024-2029)
        5.3.3 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical & Biotechnological Companies
        6.2.2 Medical Device Companies
        6.2.3 Academic & Research Institutes
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2018-2023)
        6.3.2 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2024-2029)
        6.3.3 World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2018-2029)

7 Company Profiles
    7.1 IQVIA
        7.1.1 IQVIA Details
        7.1.2 IQVIA Major Business
        7.1.3 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.1.4 IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 IQVIA Recent Developments/Updates
        7.1.6 IQVIA Competitive Strengths & Weaknesses
    7.2 ICON (Incl. PRA)
        7.2.1 ICON (Incl. PRA) Details
        7.2.2 ICON (Incl. PRA) Major Business
        7.2.3 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.2.4 ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 ICON (Incl. PRA) Recent Developments/Updates
        7.2.6 ICON (Incl. PRA) Competitive Strengths & Weaknesses
    7.3 Labcorp
        7.3.1 Labcorp Details
        7.3.2 Labcorp Major Business
        7.3.3 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.3.4 Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Labcorp Recent Developments/Updates
        7.3.6 Labcorp Competitive Strengths & Weaknesses
    7.4 Syneos Health
        7.4.1 Syneos Health Details
        7.4.2 Syneos Health Major Business
        7.4.3 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.4.4 Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Syneos Health Recent Developments/Updates
        7.4.6 Syneos Health Competitive Strengths & Weaknesses
    7.5 PPD (Thermo Fisher)
        7.5.1 PPD (Thermo Fisher) Details
        7.5.2 PPD (Thermo Fisher) Major Business
        7.5.3 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.5.4 PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 PPD (Thermo Fisher) Recent Developments/Updates
        7.5.6 PPD (Thermo Fisher) Competitive Strengths & Weaknesses
    7.6 Medpace
        7.6.1 Medpace Details
        7.6.2 Medpace Major Business
        7.6.3 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.6.4 Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Medpace Recent Developments/Updates
        7.6.6 Medpace Competitive Strengths & Weaknesses
    7.7 Parexel
        7.7.1 Parexel Details
        7.7.2 Parexel Major Business
        7.7.3 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.7.4 Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Parexel Recent Developments/Updates
        7.7.6 Parexel Competitive Strengths & Weaknesses
    7.8 Wuxi Apptec
        7.8.1 Wuxi Apptec Details
        7.8.2 Wuxi Apptec Major Business
        7.8.3 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.8.4 Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Wuxi Apptec Recent Developments/Updates
        7.8.6 Wuxi Apptec Competitive Strengths & Weaknesses
    7.9 Charles River
        7.9.1 Charles River Details
        7.9.2 Charles River Major Business
        7.9.3 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.9.4 Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Charles River Recent Developments/Updates
        7.9.6 Charles River Competitive Strengths & Weaknesses
    7.10 Pharmaron
        7.10.1 Pharmaron Details
        7.10.2 Pharmaron Major Business
        7.10.3 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.10.4 Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Pharmaron Recent Developments/Updates
        7.10.6 Pharmaron Competitive Strengths & Weaknesses
    7.11 EPS International
        7.11.1 EPS International Details
        7.11.2 EPS International Major Business
        7.11.3 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.11.4 EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 EPS International Recent Developments/Updates
        7.11.6 EPS International Competitive Strengths & Weaknesses
    7.12 Worldwide Clinical Trials
        7.12.1 Worldwide Clinical Trials Details
        7.12.2 Worldwide Clinical Trials Major Business
        7.12.3 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.12.4 Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Worldwide Clinical Trials Recent Developments/Updates
        7.12.6 Worldwide Clinical Trials Competitive Strengths & Weaknesses
    7.13 CMIC
        7.13.1 CMIC Details
        7.13.2 CMIC Major Business
        7.13.3 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.13.4 CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 CMIC Recent Developments/Updates
        7.13.6 CMIC Competitive Strengths & Weaknesses
    7.14 Inotiv
        7.14.1 Inotiv Details
        7.14.2 Inotiv Major Business
        7.14.3 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.14.4 Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Inotiv Recent Developments/Updates
        7.14.6 Inotiv Competitive Strengths & Weaknesses
    7.15 JOINN Lab
        7.15.1 JOINN Lab Details
        7.15.2 JOINN Lab Major Business
        7.15.3 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.15.4 JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 JOINN Lab Recent Developments/Updates
        7.15.6 JOINN Lab Competitive Strengths & Weaknesses
    7.16 ChemPartner
        7.16.1 ChemPartner Details
        7.16.2 ChemPartner Major Business
        7.16.3 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.16.4 ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 ChemPartner Recent Developments/Updates
        7.16.6 ChemPartner Competitive Strengths & Weaknesses
    7.17 Medicilon
        7.17.1 Medicilon Details
        7.17.2 Medicilon Major Business
        7.17.3 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.17.4 Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Medicilon Recent Developments/Updates
        7.17.6 Medicilon Competitive Strengths & Weaknesses
    7.18 EVOTEC
        7.18.1 EVOTEC Details
        7.18.2 EVOTEC Major Business
        7.18.3 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
        7.18.4 EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023)
        7.18.5 EVOTEC Recent Developments/Updates
        7.18.6 EVOTEC Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Chain
    8.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Upstream Analysis
    8.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Midstream Analysis
    8.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Contract Research Organization (CRO) and CDMO for Pharmaceutical Players in 2022
    Table 12. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Company Evaluation Quadrant
    Table 14. Head Office of Key Contract Research Organization (CRO) and CDMO for Pharmaceutical Player
    Table 15. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Type Footprint
    Table 16. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market: Company Product Application Footprint
    Table 17. Contract Research Organization (CRO) and CDMO for Pharmaceutical Mergers & Acquisitions Activity
    Table 18. United States VS China Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share (2018-2023)
    Table 23. China Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Contract Research Organization (CRO) and CDMO for Pharmaceutical Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share (2018-2023)
    Table 29. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2024-2029) & (USD Million)
    Table 35. IQVIA Basic Information, Area Served and Competitors
    Table 36. IQVIA Major Business
    Table 37. IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 38. IQVIA Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. IQVIA Recent Developments/Updates
    Table 40. IQVIA Competitive Strengths & Weaknesses
    Table 41. ICON (Incl. PRA) Basic Information, Area Served and Competitors
    Table 42. ICON (Incl. PRA) Major Business
    Table 43. ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 44. ICON (Incl. PRA) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. ICON (Incl. PRA) Recent Developments/Updates
    Table 46. ICON (Incl. PRA) Competitive Strengths & Weaknesses
    Table 47. Labcorp Basic Information, Area Served and Competitors
    Table 48. Labcorp Major Business
    Table 49. Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 50. Labcorp Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Labcorp Recent Developments/Updates
    Table 52. Labcorp Competitive Strengths & Weaknesses
    Table 53. Syneos Health Basic Information, Area Served and Competitors
    Table 54. Syneos Health Major Business
    Table 55. Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 56. Syneos Health Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Syneos Health Recent Developments/Updates
    Table 58. Syneos Health Competitive Strengths & Weaknesses
    Table 59. PPD (Thermo Fisher) Basic Information, Area Served and Competitors
    Table 60. PPD (Thermo Fisher) Major Business
    Table 61. PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 62. PPD (Thermo Fisher) Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. PPD (Thermo Fisher) Recent Developments/Updates
    Table 64. PPD (Thermo Fisher) Competitive Strengths & Weaknesses
    Table 65. Medpace Basic Information, Area Served and Competitors
    Table 66. Medpace Major Business
    Table 67. Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 68. Medpace Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Medpace Recent Developments/Updates
    Table 70. Medpace Competitive Strengths & Weaknesses
    Table 71. Parexel Basic Information, Area Served and Competitors
    Table 72. Parexel Major Business
    Table 73. Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 74. Parexel Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Parexel Recent Developments/Updates
    Table 76. Parexel Competitive Strengths & Weaknesses
    Table 77. Wuxi Apptec Basic Information, Area Served and Competitors
    Table 78. Wuxi Apptec Major Business
    Table 79. Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 80. Wuxi Apptec Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Wuxi Apptec Recent Developments/Updates
    Table 82. Wuxi Apptec Competitive Strengths & Weaknesses
    Table 83. Charles River Basic Information, Area Served and Competitors
    Table 84. Charles River Major Business
    Table 85. Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 86. Charles River Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Charles River Recent Developments/Updates
    Table 88. Charles River Competitive Strengths & Weaknesses
    Table 89. Pharmaron Basic Information, Area Served and Competitors
    Table 90. Pharmaron Major Business
    Table 91. Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 92. Pharmaron Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Pharmaron Recent Developments/Updates
    Table 94. Pharmaron Competitive Strengths & Weaknesses
    Table 95. EPS International Basic Information, Area Served and Competitors
    Table 96. EPS International Major Business
    Table 97. EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 98. EPS International Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. EPS International Recent Developments/Updates
    Table 100. EPS International Competitive Strengths & Weaknesses
    Table 101. Worldwide Clinical Trials Basic Information, Area Served and Competitors
    Table 102. Worldwide Clinical Trials Major Business
    Table 103. Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 104. Worldwide Clinical Trials Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Worldwide Clinical Trials Recent Developments/Updates
    Table 106. Worldwide Clinical Trials Competitive Strengths & Weaknesses
    Table 107. CMIC Basic Information, Area Served and Competitors
    Table 108. CMIC Major Business
    Table 109. CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 110. CMIC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. CMIC Recent Developments/Updates
    Table 112. CMIC Competitive Strengths & Weaknesses
    Table 113. Inotiv Basic Information, Area Served and Competitors
    Table 114. Inotiv Major Business
    Table 115. Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 116. Inotiv Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Inotiv Recent Developments/Updates
    Table 118. Inotiv Competitive Strengths & Weaknesses
    Table 119. JOINN Lab Basic Information, Area Served and Competitors
    Table 120. JOINN Lab Major Business
    Table 121. JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 122. JOINN Lab Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. JOINN Lab Recent Developments/Updates
    Table 124. JOINN Lab Competitive Strengths & Weaknesses
    Table 125. ChemPartner Basic Information, Area Served and Competitors
    Table 126. ChemPartner Major Business
    Table 127. ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 128. ChemPartner Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. ChemPartner Recent Developments/Updates
    Table 130. ChemPartner Competitive Strengths & Weaknesses
    Table 131. Medicilon Basic Information, Area Served and Competitors
    Table 132. Medicilon Major Business
    Table 133. Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 134. Medicilon Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 135. Medicilon Recent Developments/Updates
    Table 136. EVOTEC Basic Information, Area Served and Competitors
    Table 137. EVOTEC Major Business
    Table 138. EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Product and Services
    Table 139. EVOTEC Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 140. Global Key Players of Contract Research Organization (CRO) and CDMO for Pharmaceutical Upstream (Raw Materials)
    Table 141. Contract Research Organization (CRO) and CDMO for Pharmaceutical Typical Customers
List of Figure
    Figure 1. Contract Research Organization (CRO) and CDMO for Pharmaceutical Picture
    Figure 2. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue (2018-2029) & (USD Million)
    Figure 13. Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Contract Research Organization (CRO) and CDMO for Pharmaceutical by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Contract Research Organization (CRO) and CDMO for Pharmaceutical Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Contract Research Organization (CRO) and CDMO for Pharmaceutical Markets in 2022
    Figure 27. United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Contract Research Organization (CRO) and CDMO for Pharmaceutical Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Market Share by Type in 2022
    Figure 31. Preclinical CROs
    Figure 32. Clinical CROs
    Figure 33. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Market Share by Type (2018-2029)
    Figure 34. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Market Share by Application in 2022
    Figure 36. Pharmaceutical & Biotechnological Companies
    Figure 37. Medical Device Companies
    Figure 38. Academic & Research Institutes
    Figure 39. Others
    Figure 40. Contract Research Organization (CRO) and CDMO for Pharmaceutical Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

IQVIA
ICON (Incl. PRA)
Labcorp
Syneos Health
PPD (Thermo Fisher)
Medpace
Parexel
Wuxi Apptec
Charles River
Pharmaron
EPS International
Worldwide Clinical Trials
CMIC
Inotiv
JOINN Lab
ChemPartner
Medicilon
EVOTEC

Related Reports

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 13 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 16 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Contract Research Organization (CRO) and CDMO for Pharmaceutical

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>